Health
The GLP-1 Era: How Weight-Loss Drugs Changed Us
Semaglutide and tirzepatide went from diabetes treatment to celebrity shortcut to a genuine health story. What happens when one drug becomes a cultural moment.
Apr 20, 2024
Loading
Search
Results
24 stories for“obesity research”
Health
Retatrutide Is Not Approved in Any Country. It Is Also for Sale in Most of Them
Lilly does not expect to file for approval until the first quarter of 2027. Search the drug's name today and you can have a vial by the weekend. The gap between those two facts is where the harm happens.
Aug 20, 2026
Health
What GLP-1 Drugs Actually Cost in the UAE Right Now
Ozempic, Wegovy and Mounjaro are all prescribable in the UAE, but shortages and insurance gaps shape who can actually get them.
Mar 10, 2025
Health
Muscle Loss on GLP-1s: What the Evidence Really Shows
New body composition data compares lean mass loss on tirzepatide and semaglutide. Here is what is measured, and what remains unclear.
Jun 15, 2026
Health
A Tape Measure Round the Waist Did the Same Job as Four Measurements and a Formula
In 1,900 American adults, waist circumference on its own matched a new multi measurement framework against a proper body fat scan. BMI alone missed a substantial number of people who met the body fat criteria for obesity.
Sep 1, 2026
Health
Exercise as Treatment: What Trials Show for Depression and Anxiety
Meta-analyses now put exercise's effect on depression in the same range as antidepressant trials, with real implications for regions like the Gulf.
Apr 14, 2026
Health
Retatrutide: The Triple Agonist Still Proving Itself
Retatrutide just posted phase 3 weight loss data hitting three hormone receptors at once. Here is what is confirmed and what remains unproven.
May 27, 2026
Health
GLP-1 Drugs Are Becoming More Than Weight Loss Medicine
Tirzepatide just earned an approval that has nothing to do with the scale. Here is what SELECT, FLOW and the new sleep apnea data show.
Jan 8, 2025
Health
Ozempic and Wegovy: What the Trials Actually Showed
Semaglutide now has a heart disease approval too. Here is what the STEP and SELECT trial data really says, and what it does not.
Mar 13, 2024
Health
What Actually Happens When You Stop Taking a GLP-1
Trial data on stopping semaglutide shows most of the lost weight comes back within a year. Here is what the STEP 1 extension found.
May 15, 2024
Health
Berberine and the 'Nature's Ozempic' Claim: What Evidence Shows
Berberine lowers cholesterol and blood sugar in small trials, but comparing it to semaglutide misreads both the data and the biology.
Feb 14, 2024
Health
A Daily Weight-Loss Pill Worked Just as Well for Women at Every Stage of Menopause, New Trial Data Show
New analyses of the ATTAIN trials presented at the European Association for the Study of Diabetes found orforglipron cut body weight by up to 14 per cent regardless of whether women were premenopausal, perimenopausal or postmenopausal.
Sep 29, 2026
Health
Intermittent Fasting Works About as Well as Eating Less, Because in the Trials That Is What It Turned Out to Be
Three randomised trials put time-restricted eating against ordinary calorie control or against nothing. The eating window on its own did little. Combined with eating less, it did what eating less does. What that means for anyone considering it.
Sep 6, 2026
Health
Bats Carry Viruses That Should Kill Them, and Science Just Found Another Piece of the Answer
More than 500 species of vesper bat turn out to carry two separate sets of antibody heavy chain genes, where every other known mammal has one. The researchers are careful to say this does not fully explain why bats tolerate viruses.
Sep 4, 2026
Health
Loneliness Raises the Risk of Early Death by About a Quarter, and the World Health Organization Now Counts It as a Cause
A meta-analysis of seventy studies put the increased mortality risk from loneliness at 26 per cent and from living alone at 32 per cent. A WHO commission estimates 871,000 deaths a year. What the numbers mean, and what has been shown to help.
Aug 23, 2026
